Skip to main content
SpringerLink
Log in

Säureassoziierte Beschwerden nach Beendigung einer PPI-Therapie

  • Für Sie gelesen
  • Published:
Der Gastroenterologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hunfeld NG, Geus WP, Kuipers EJ (2007) Rebound acid hypersecretion after therapy with proton pump inhibitors. Aliment Pharmacol Ther 25: 39–46

    Article  PubMed  CAS  Google Scholar 

  2. Talley NJ, Vakil NB, Moayyedi P (2005) American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 129: 1756–1780

    Article  PubMed  Google Scholar 

  3. Malfertheiner P, Holtmann G, Peitz U et al (2001) Guidelines of the German Society of Digestive and Metabolic Diseases for Treatment of Dyspepsia. Z Gastroenterol 39: 937–956

    Article  PubMed  CAS  Google Scholar 

  4. Ragunath AS, O’Morain C, McLoughlin RC (2005) Review article: the long-term use of proton pump inhibitors. Aliment Pharmacol Ther 22 (Suppl 1): 55–63

    Article  Google Scholar 

  5. Lassen A, Hallas J, Schaffalitzky de Muckadell OB (2004) Use of anti-secretory medications: a population-based cohort study. Aliment Pharmacol Ther: 577–583

    Article  Google Scholar 

Download references

Interessenkonflikt

Der Autor Dr. Andreas Leodolter ist als Referent und Berater für die Firma AstraZeneca tätig

Author information

Authors and Affiliations

  1. Medizinische Klinik, Ev. Jung-Stilling-Krankenhaus, Wichernstr. 40, 57074, Siegen, Deutschland

    A. Leodolter

Authors
  1. A. Leodolter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Leodolter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leodolter, A. Säureassoziierte Beschwerden nach Beendigung einer PPI-Therapie. Gastroenterologe 4, 352–353 (2009). https://doi.org/10.1007/s11377-009-0323-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-009-0323-1

Search

Navigation